TITLE

Biologics' efficacy data growing

AUTHOR(S)
Jesitus, John
PUB. DATE
September 2005
SOURCE
Dermatology Times;Sep2005 Supplement 4, Vol. 25, pS19
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the advantages of longer treatment regimens and combinations with other modalities by use of biologic drugs for psoriasis treatment. Problems of alefacept; Observations on patients treated with alefacept; Advantages of combined therapies for psoriasis.
ACCESSION #
18347991

 

Related Articles

  • Offer systemic therapy as first-line defense. Rutledge, Barbara J. // Dermatology Times;Sep2005 Supplement 4, Vol. 25, pS16 

    Evaluates the efficacy of alefacept therapy as first-line defense for psoriasis. Impact of psoriasis on the quality of life of the patient; Number of people affected with the disease of the year; Treatment paradigms for psoriasis.

  • Living with Psoriasis. Paranzino, Michael // FDA Consumer;Sep2004, Vol. 38 Issue 5, p40 

    Reflects on life as a psoriasis patient. Characterization of the disease; Physical and emotional effects of psoriasis; Increase in the efforts of the U.S. government to develop psoriasis treatment.

  • Systemics remain relevant psoriasis Rx. Nataloni, Rochelle // Dermatology Times;Sep2005 Supplement 4, Vol. 25, pS18 

    Reports that systemic drugs, from cyclosporine to methotrexate has retained a relevant role in the treatment of psoriasis despite of all encompassing focus on biologics. Comments of Bruce E. Strober, assistant professor of dermatology in New York University School of Medicine, New York, on the...

  • Physician says TNF-a antagonists very safe, overall. Guttman, Cheryl // Dermatology Times;Sep2004 Supplement, Vol. 25, pS33 

    Reports that TNF-a antagonists are safe for psoriatic patients. Presentation of several antagonists safe for psoriatic therapy; Discussion on the risks of serious infections and malignancies related to the immunosuppressive activity of the TNF-a antagonist; Effects on patients after treated with...

  • THE PATIENT'S PERSPECTIVE. . Pickering, Henry // British Journal of General Practice;Feb2010, Vol. 60 Issue 571, p140 

    A personal narrative is presented which explores the author's experience of having psoriasis, particularly citing various drugs he used to treat the disease such as Betnovate cream, butazolidin and Acitretin.

  • Treatment failure rate, costs high in moderate-to-severe psoriasis.  // PharmacoEconomics & Outcomes News;3/12/2005, Issue 473, p8 

    Presents information on high medical costs observed among patients with moderate-to-severe psoriasis in the U.S. Use of claims data to examine systemic prescription drug and healthcare service among patients with moderate-to-severe psoriasis to assess treatment failure rates and medical costs;...

  • The Effect of Navakarshaka Kashaya Ghana satwa in the Management of Ekakushta (Psoriasis): A Randomized Comparative Single Blind Clinical Trial. Raghavendra, Y.; Kashavva, Hiremath V. // Indian Journal of Ancient Medicine & Yoga;Jul-Sep2014, Vol. 7 Issue 3, p125 

    Background: It's difficult to lead the life with skin disease as it account for a great deal of misery, suffering, incapacity and economic loss. Ekakushta is a vatakapha pradhana tridoshaja vyadhi and is prime among the Kshudra kushtas and its lakshanas resembles with the Psoriasis. There is a...

  • No cure for psoriasis, but treatments can help. Pinette, Dr. Gilles // Saskatchewan Sage;Apr2004, Vol. 8 Issue 7, p13 

    Psoriasis is a common condition that causes red or purple scaly patches on your skin. Psoriasis is pronounced "sore-eye-a-sis." These patches may be thick with a rough surface, and may be on the knees, elbows and scalp or they may be widespread across the entire body. The exact cause of...

  • tazarotene.  // Royal Society of Medicine: Medicines;2002, p523 

    The article presents information on tazarotene which is chemically a derivative of retinol or vitamin A. This drug can be used to treat mild to moderate plaque psoriasis. Administration is by topical application. It should not be used in pregnancy or breast-feeding. Patients should wash hands...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics